Vicarious Surgical Inc. (RBOT)
NYSE: RBOT · Real-Time Price · USD
5.39
-0.02 (-0.37%)
At close: Apr 17, 2025, 4:00 PM
5.34
-0.05 (-0.88%)
After-hours: Apr 17, 2025, 7:39 PM EDT
Vicarious Surgical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Vicarious Surgical stock have an average target of 9.25, with a low estimate of 8.50 and a high estimate of 10. The average target predicts an increase of 71.61% from the current stock price of 5.39.
Analyst Consensus: Hold
* Price targets were last updated on Mar 18, 2025.
Analyst Ratings
The average analyst rating for Vicarious Surgical stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 4 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Hold Maintains $11 → $8.5 | Hold | Maintains | $11 → $8.5 | +57.70% | Mar 18, 2025 |
Piper Sandler | Piper Sandler | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +94.81% | Nov 13, 2024 |
Piper Sandler | Piper Sandler | Hold Maintains $30 → $12 | Hold | Maintains | $30 → $12 | +122.63% | Aug 13, 2024 |
Morgan Stanley | Morgan Stanley | Hold Maintains $18 → $10 | Hold | Maintains | $18 → $10 | +85.53% | Jul 15, 2024 |
Piper Sandler | Piper Sandler | Hold Maintains $45 → $30 | Hold | Maintains | $45 → $30 | +456.59% | Mar 5, 2024 |
Financial Forecast
Revenue This Year
n/a
from 68.24M
Revenue Next Year
n/a
EPS This Year
-8.88
from -10.74
EPS Next Year
-6.92
from -8.88
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 37.8M | ||
Avg | n/a | n/a | 22.4M | ||
Low | n/a | n/a | 8.7M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -7.58 | -3.72 | -2.90 |
Avg | -8.88 | -6.92 | -5.49 |
Low | -9.99 | -9.72 | -9.01 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.